The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age35-79
SponsorBrigham and Women's Hospital
About this trial
Individuals with rheumatoid arthritis (RA) have up to 2x the risk of having a heart attack compared to someone without RA. The goal of this study is to identify biomarkers that can help us do a better job of identifying individuals at risk before they develop symptoms of heart disease and start preventative treatment earlier.
Eligibility criteria
Qualifiers
RA diagnosed by a rheumatologist
Age 40- 79
≥1 ASCVD risk factor including prediabetes, hypertension, BMI >30, current or history of cigarette smoking
Disqualifiers
Patients on a statin or with a contraindication to statin, on a cholesterol absorption inhibitor, or on a PCSK9 inhibitor
Patients with diabetes mellitus
Pregnancy
Trial design
Treatments tested in this trial
- high sensitivity cardiac troponin
Treatment groups
No treatment groups listed
Locations
1Brigham and Womens Hospital02115, BostonMassachusetts, United States
Sponsors and collaborators
Brigham and Women's Hospital
Lead sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator
Source ClinicalTrials.gov